Bristol JA - Search Results

1

Propeptide processing during factor IX biosynthesis. Effect of point mutations adjacent to the propeptide cleavage site.

Bristol JA, Furie BC, Furie B. Bristol JA, et al. J Biol Chem. 1993 Apr 5;268(10):7577-84. J Biol Chem. 1993. PMID: 8463288 Free article.

2

Profactor IX: the propeptide inhibits binding to membrane surfaces and activation by factor XIa.

Bristol JA, Freedman SJ, Furie BC, Furie B. Bristol JA, et al. Biochemistry. 1994 Nov 29;33(47):14136-43. doi: 10.1021/bi00251a024. Biochemistry. 1994. PMID: 7947825

3

Biosynthesis of prothrombin: intracellular localization of the vitamin K-dependent carboxylase and the sites of gamma-carboxylation.

Bristol JA, Ratcliffe JV, Roth DA, Jacobs MA, Furie BC, Furie B. Bristol JA, et al. Blood. 1996 Oct 1;88(7):2585-93. Blood. 1996. PMID: 8839851 Free article.

4

PACE/furin can process the vitamin K-dependent pro-factor IX precursor within the secretory pathway.

Wasley LC, Rehemtulla A, Bristol JA, Kaufman RJ. Wasley LC, et al. Among authors: bristol ja. J Biol Chem. 1993 Apr 25;268(12):8458-65. J Biol Chem. 1993. PMID: 8473289 Free article.

5

Effects on CD4 binding of anti-peptide sera to the fourth and fifth conserved domains of HIV-1 gp120.

Ardman B, Kowalski M, Bristol J, Haseltine W, Sodroski J. Ardman B, et al. J Acquir Immune Defic Syndr (1988). 1990;3(3):206-14. J Acquir Immune Defic Syndr (1988). 1990. PMID: 2304000

6

Surface immunoglobulin-positive T lymphocytes in HIV-1 infection: relationship to CD4+ lymphocyte depletion.

Ardman B, Mayer K, Bristol J, Ryan M, Settles M, Levy E. Ardman B, et al. Clin Immunol Immunopathol. 1990 Aug;56(2):249-58. doi: 10.1016/0090-1229(90)90146-h. Clin Immunol Immunopathol. 1990. PMID: 1974180

7

N6-substituted adenosine receptor agonists: potential antihypertensive agents.

Trivedi BK, Blankley CJ, Bristol JA, Hamilton HW, Patt WC, Kramer WJ, Johnson SA, Bruns RF, Cohen DM, Ryan MJ. Trivedi BK, et al. Among authors: bristol ja. J Med Chem. 1991 Mar;34(3):1043-9. doi: 10.1021/jm00107a025. J Med Chem. 1991. PMID: 2002448

8

N6-(2,2-diphenylethyl)adenosine, a novel adenosine receptor agonist with antipsychotic-like activity.

Bridges AJ, Moos WH, Szotek DL, Trivedi BK, Bristol JA, Heffner TG, Bruns RF, Downs DA. Bridges AJ, et al. Among authors: bristol ja. J Med Chem. 1987 Oct;30(10):1709-11. doi: 10.1021/jm00393a003. J Med Chem. 1987. PMID: 2888894 No abstract available.

9

Synthesis of xanthines as adenosine antagonists, a practical quantitative structure-activity relationship application.

Hamilton HW, Ortwine DF, Worth DF, Badger EW, Bristol JA, Bruns RF, Haleen SJ, Steffen RP. Hamilton HW, et al. Among authors: bristol ja. J Med Chem. 1985 Aug;28(8):1071-9. doi: 10.1021/jm00146a016. J Med Chem. 1985. PMID: 2991519

10

Ribose-modified adenosine analogues as adenosine receptor agonists.

Taylor MD, Moos WH, Hamilton HW, Szotek DS, Patt WC, Badger EW, Bristol JA, Bruns RF, Heffner TG, Mertz TE. Taylor MD, et al. Among authors: bristol ja. J Med Chem. 1986 Mar;29(3):346-53. doi: 10.1021/jm00153a008. J Med Chem. 1986. PMID: 3005574

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

63 results

Search Page